What is Advanced Solutions?
Advanced Solutions operates at the intersection of robotics and life sciences, specializing in advanced 3D bioprinting and biofabrication. The company's core innovation, the BioAssemblyBot, serves as a sophisticated robotic platform engineered to construct complex, vascularized human tissues with unprecedented precision. By lowering the barriers to entry for tissue engineering, the firm provides essential infrastructure for researchers and clinicians engaged in drug discovery and organ development. As a prominent participant in the ARMI ecosystem, Advanced Solutions is effectively bridging the gap between laboratory-scale experimentation and clinical-grade tissue manufacturing, establishing a robust market position in the high-growth biotechnology landscape.
How much funding has Advanced Solutions raised?
Advanced Solutions has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Advanced Solutions
PPP
Public-Private Partnership
What's next for Advanced Solutions?
Following this significant financing round, Advanced Solutions is expected to prioritize the commercial expansion of its BioAssemblyBot platform. The strategic deployment of these funds will likely focus on enhancing manufacturing throughput and expanding the company's footprint within global research institutions. By leveraging this capital, the firm aims to refine its biofabrication protocols, thereby reducing costs and increasing the accessibility of its technology for large-scale clinical applications. Future growth will likely be driven by strategic partnerships and the continued integration of its robotic systems into the workflows of pharmaceutical companies seeking to optimize drug discovery processes through more accurate human tissue models.
See full Advanced Solutions company page
